Schott Pharma & CO. (1SXP.XETRA) Q3 2024 Earnings

29AugConfirmed
Q4 2023
Q2 2024
Q3 2024
0.17
0.21
0.25
0.3

Details

Expected EPS
0.1969162721758848
Actual EPS
0.29344986479202245
Surprise EPS
0.1
Surprise Percent
+49.02%

Description

Schott Pharma & CO. (1SXP.XETRA) has reported earnings of 0.29344986479202245 per share for Q3 2024.

0 Comments

Share your thoughts